UPDATE 1-Ariad Pharma CEO Berger to retire in deal with top investor April 29- Ariad Pharmaceuticals Inc said Chief Executive Harvey Berger would retire as part of a deal to settle its proxy battle with largest shareholder Sarissa Capital Management. Ariad's shares were up 4 percent at $9.22 in premarket trading. Sarissa, an activist fund run by investor Carl Icahn's former healthcare lieutenant, Alex Denner, holds a 6.85...
CNBC update: Jodi Arias sentencing A judge sentenced Jodi Arias to life without parole; United States Secretary of State John Kerry objects to Russia's missile sale to Iran; and Italy coast guard rescued thousands of migrants from sea, reports CNBC's Sue Herera.
Trading Nation, April 13, 2015 Tod Gordon TradingAnalysis.com and David Seaburg of Cowen, discuss their best trading ideas and what stocks they'll be watching.